Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals.

21 Nov 2024

Decoding the genetic roots of stroke and heart attack

In a new study published in the European Heart Journal, researchers at Karolinska Institutet show that genetic traits influence the cellular composition of atherosclerotic plaques, which over time will affect the risk of such lesions to cause a stroke or heart attack. The new knowledge can be used to improve the risk assessment and treatment of patients with atherosclerosis in the future.

20 Nov 2024

Online group programs aid weight loss but face hurdles

Online, group-based interventions show promise for weight loss in adults with severe obesity, though barriers like digital literacy and engagement need addressing.

20 Nov 2024

Children's Colorado earns prestigious cardiomyopathy recognition

Children's Hospital Colorado (Children's Colorado) has been named a Cardiomyopathy Center of Care by the Children's Cardiomyopathy Foundation (CCF), a national nonprofit committed to improving health outcomes and quality of life for children with cardiomyopathy.

20 Nov 2024

CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis

A new type of therapy that 'edits' a gene in patients with a rare heart condition has been shown to be safe and effective, according to research from UCL and the Royal Free Hospital.

20 Nov 2024

Study links GERD to increased cardiovascular risk factors

A recent study published in the Journal of Translational Internal Medicine (https://doi.org/10.1515/jtim-2024-0017) reveals significant insights into the broader impact of gastroesophageal reflux disease (GERD) on cardiovascular health.

20 Nov 2024

Cardiorespiratory fitness trumps BMI in predicting risk of death and heart disease

As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs.

20 Nov 2024

More than half of all US adults are eligible for semaglutide therapy

Over 137 million US adults are eligible for semaglutide, driven by expanding indications for diabetes, weight management, and cardiovascular disease prevention.

20 Nov 2024

Can probiotics improve insulin resistance in women with PCOS?

The review highlights the role of probiotics and synbiotics in enhancing insulin sensitivity and hormonal balance in PCOS, suggesting new avenues for treatment.

20 Nov 2024

Survival chances found to be significantly better for sports-related cardiac arrest

Most cases of cardiac arrest during sport are likely to be preventable. In addition, the emergency response with cardiopulmonary resuscitation (CPR) and defibrillators within the sports context can be improved.

19 Nov 2024

Muvalaplin shows promise in lowering Lp(a) levels in clinical trial

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

19 Nov 2024

Common cardiovascular drugs linked to lower risk of dementia

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska Institutet published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

19 Nov 2024

New research links sphingolipids to heart disease and atherosclerosis

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

19 Nov 2024

Study reveals variability in polygenic risk scores for predicting heart disease

Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to estimate a person's risk of developing certain diseases, such as coronary artery disease (CAD).

19 Nov 2024

Coronary artery calcium scores found to predict risk of heart attack and death in both men and women

Coronary artery calcium (CAC) scores have become a non-invasive way for physicians to easily determine how much plaque has built up inside a patient's coronary arteries, but the question has been how accurate the score is in identifying women, as well as men, who are at high risk for a heart attack or death.

19 Nov 2024

Benefits of sport and leisure activities outweigh the risks for people with heart disease, cardiologists say

While exercise is generally beneficial for a person's overall health, physical activities may increase the risk of adverse cardiovascular disease events in certain susceptible individuals. However, cardiologists say that the benefits outweigh the risks.

19 Nov 2024

Study: 40% of newly diagnosed heart failure patients also have atrial fibrillation

A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders that researchers found results in significantly poorer outcomes for patients.

19 Nov 2024

New nasal spray form of bumetanide shows promise for heart failure treatment

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

19 Nov 2024

Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association's 2024 Scientific Sessions.

19 Nov 2024